Skip to Content
Intellectual Property and Assessing its Financial Value
book

Intellectual Property and Assessing its Financial Value

by Benedikt Sas, Stanislas De Vocht, Philippe Jacobs
December 2014
Beginner
200 pages
8h 3m
English
Chandos Publishing
Content preview from Intellectual Property and Assessing its Financial Value
38
Intellectual Property and Assessing Its Financial Value
the development of antibody-derived therapeutic molecules. The second
example concerns one US application of the >18,000 patents and/or
patent applications of the US company Genentech (currently belonging
to the Roche group), which conducts research in the areas of oncology,
immunology, neuroscience, metabolism, and infectious disease.
Making claims too broad is also not recommended, because the
patent examiner can decide that there are multiple inventions (there is
no “unity” of invention) which all need to be filed separately, or the
claims may be so broad that they encompass the prior ...
Become an O’Reilly member and get unlimited access to this title plus top books and audiobooks from O’Reilly and nearly 200 top publishers, thousands of courses curated by job role, 150+ live events each month,
and much more.
Start your free trial

You might also like

Intellectual Property: Valuation, Exploitation and Infringement Damages 2013 Cumulative Supplement, 11th Edition

Intellectual Property: Valuation, Exploitation and Infringement Damages 2013 Cumulative Supplement, 11th Edition

Russell L. Parr

Publisher Resources

ISBN: 9781843347927